{"": [102, 1901, 0], "INTRODUCTION": [1902, 5625, 0], "Characterization of SARS-CoV-2 S glycoproteins in cell lysates and virus-like particles": [5635, 7210, 0], "Expression and purification of the SARS-CoV-2 S glycoprotein": [7211, 9697, 0], "Disulfide and glycosylation analysis of the purified S glycoproteins": [9698, 15396, 0], "SARS-CoV-2 S glycoprotein expression in a cell line with defective glycosylation": [15397, 18038, 0], "Natural variants of SARS-CoV-2 S glycoproteins": [18039, 21379, 0], "RESULTS": [5626, 21379, 1], "DISCUSSION": [21380, 27406, 0], "Reagents": [27432, 28212, 0], "Plasmids": [28213, 29574, 0], "Cell lines": [29575, 30637, 0], "Expression and processing of S glycoprotein variants": [30638, 32826, 0], "S1 shedding from S glycoprotein-expressing cells": [32827, 33494, 0], "Purification of the S glycoproteins": [33495, 35401, 0], "Proteolytic digestion of SARS-CoV-2 spike glycoproteins for glycosylation analysis": [35402, 36717, 0], "Disulfide bond analysis of SARS-CoV-2 spike glycoprotein": [36718, 37660, 0], "Chromatography and mass spectrometry": [37661, 39151, 0], "Glycopeptide identification and disulfide bond analysis": [39152, 39973, 0], "VSV pseudotyped by S glycoproteins": [39974, 40934, 0], "Syncytium formation assay": [40935, 41383, 0], "Virus infectivity": [41384, 41622, 0], "Virus neutralization by sACE2 and sera": [41623, 42245, 0], "EXPERIMENTAL PROCEDURES": [27407, 42245, 1]}